The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Turka Laurence A. since 2022.
This trader's CIK number is 1800952.
At the time of last reporting, Turka Laurence A. was the Chief Scientific Officer of Rubius Therapeutics, Inc.. (stock ticker symbol RUBY).
Also see all insider trading activities at Rubius Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | RUBY | 0 | $0 | 2,593 | $622 | 16,063 | $0 |
| 2022 | RUBY | 0 | $0 | 2,517 | $16,544 | 7,438 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-01-31 | RUBY | Sale | 2,593 | .24 | 622 |
| 2023-01-31 | RUBY | Option Ex | 8,625 | .00 | 0 |
| 2023-01-29 | RUBY | Option Ex | 7,438 | .00 | 0 |
| 2022-02-01 | RUBY | Sale | 2,517 | 6.57 | 16,544 |
| 2022-01-29 | RUBY | Option Ex | 7,438 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Turka Laurence A. (Chief Scientific Officer of Rubius Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.